This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
OKYO 株式概要
A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.
OKYO Pharma Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | UK£0.91 |
| 52週高値 | UK£3.90 |
| 52週安値 | UK£0.88 |
| ベータ | -0.062 |
| 11ヶ月の変化 | -9.68% |
| 3ヶ月変化 | -65.69% |
| 1年変化 | -63.64% |
| 33年間の変化 | -45.10% |
| 5年間の変化 | n/a |
| IPOからの変化 | -98.13% |
最新ニュース
Recent updates
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?
Nov 26
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?
Jan 27Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation
Sep 22We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth
Mar 17We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow
Dec 02株主還元
| OKYO | GB Biotechs | GB 市場 | |
|---|---|---|---|
| 7D | -31.7% | 4.7% | 1.4% |
| 1Y | -63.6% | -16.4% | 8.1% |
業界別リターン: OKYO underperformed the UK Biotechs industry which returned -16.5% over the past year.
リターン対市場: OKYO underperformed the UK Market which returned -2.2% over the past year.
価格変動
| OKYO volatility | |
|---|---|
| OKYO Average Weekly Movement | 18.1% |
| Biotechs Industry Average Movement | 7.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.5% |
| 10% least volatile stocks in GB Market | 2.6% |
安定した株価: OKYO's share price has been volatile over the past 3 months.
時間の経過による変動: OKYO's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of UK stocks.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2007 | 7 | Gary Jacob | okyopharma.com |
OKYO Pharma Limited 基礎のまとめ
| OKYO 基礎統計学 | |
|---|---|
| 時価総額 | UK£23.22m |
| 収益（TTM） | -UK£6.70m |
| 売上高(TTM) | n/a |
0.0x
P/Sレシオ-3.5x
PER（株価収益率OKYO は割高か？
公正価値と評価分析を参照収益と収入
| OKYO 損益計算書（TTM） | |
|---|---|
| 収益 | UK£0 |
| 売上原価 | UK£4.39m |
| 売上総利益 | -UK£4.39m |
| その他の費用 | UK£2.31m |
| 収益 | -UK£6.70m |
直近の収益報告
Sep 30, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -0.26 |
| グロス・マージン | 0.00% |
| 純利益率 | 0.00% |
| 有利子負債／自己資本比率 | 0% |
OKYO の長期的なパフォーマンスは？
過去の実績と比較を見る